ETR:SBS Stratec (SBS) Stock Price, News & Analysis €25.50 +0.30 (+1.19%) As of 04/28/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesBuy This Stock About Stratec Stock (ETR:SBS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Stratec alerts:Sign Up Key Stats Today's Range€25.25▼€25.8550-Day Range€22.35▼€30.8052-Week Range€36.00▼€49.65Volume7,782 shsAverage Volume6,253 shsMarket Capitalization$306.35 millionP/E Ratio30.60Dividend Yield2.16%Price TargetN/AConsensus RatingN/A Company OverviewStratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.Read More… Receive SBS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Stratec and its competitors with MarketBeat's FREE daily newsletter. Email Address SBS Stock News HeadlinesStratec SE (SBS.BE)April 13, 2025 | uk.finance.yahoo.comStratec (ETR:SBS) Hasn't Managed To Accelerate Its ReturnsMarch 25, 2025 | finance.yahoo.comWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead.April 29, 2025 | Altimetry (Ad)EQS-News: STRATEC ANNOUNCES CHANGES TO 2025 FINANCIAL CALENDARMarch 19, 2025 | markets.businessinsider.comStratec Announces Changes to 2025 Financial CalendarMarch 19, 2025 | finance.yahoo.comEQS-News: STRATEC RECEIVES VALIDATION OF ITS CLIMATE TARGETS FROM THE SCIENCE BASED TARGETS INITIATIVE (SBTi)March 15, 2025 | markets.businessinsider.comInstitutional owners may consider drastic measures as Stratec SE's (ETR:SBS) recent €44m drop adds to long-term lossesFebruary 20, 2025 | finance.yahoo.comAre Stratec SE's (ETR:SBS) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?January 18, 2025 | finance.yahoo.comSee More Headlines SBS Stock Analysis - Frequently Asked Questions How have SBS shares performed this year? Stratec's stock was trading at €29.80 on January 1st, 2025. Since then, SBS shares have decreased by 14.4% and is now trading at €25.50. View the best growth stocks for 2025 here. What other stocks do shareholders of Stratec own? Based on aggregate information from My MarketBeat watchlists, some other companies that Stratec investors own include Great Portland Estates (GPOR), Gogo (GOGO), Depomed (DEPO), Cenovus Energy (CVE), China Hydroelectric Corp Foreign (CHC), Bio-Rad Laboratories (BIO) and Berkshire Hills Bancorp (BHLB). Industry, Sector and Symbol Stock ExchangeETR SectorMedical Industry Medical Devices Sub-IndustryUtilities Current SymbolETR:SBS CIKN/A Webwww.stratec.com Phone+49-7082-79160FaxN/AEmployees1,464Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)€0.83 Trailing P/E Ratio30.24 Forward P/E Ratio7.00 P/E Growth10.43Net Income$9.89 million Net Margins4.00% Pretax MarginN/A Return on Equity4.36% Return on Assets4.09% Debt Debt-to-Equity Ratio66.97 Current Ratio2.52 Quick Ratio1.65 Sales & Book Value Annual Sales$247.60 million Price / Sales1.22 Cash Flow€1.06 per share Price / Cash Flow23.85 Book Value€18.74 per share Price / Book1.34Miscellaneous Outstanding Shares12,013,727Free FloatN/AMarket Cap$302.75 million OptionableNot Optionable Beta0.16 Beginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (ETR:SBS) was last updated on 4/29/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stratec SE Please log in to your account or sign up in order to add this asset to your watchlist. Share Stratec With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
